| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:16 UTC |
|---|
| Update date | 2019-11-26 03:07:11 UTC |
|---|
| Primary ID | FDB012605 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Psoralen |
|---|
| Description | Psoralen, also known as ficusin or manaderm, belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one. Psoralen is found, on average, in the highest concentration within a few different foods, such as figs (Ficus carica), parsleys (Petroselinum crispum), and parsnips (Pastinaca sativa) and in a lower concentration in fennels (Foeniculum vulgare), lovages (Levisticum officinale), and wild carrots (Daucus carota). Psoralen has also been detected, but not quantified in, several different foods, such as kales (Brassica napus var. pabularia), persian limes (Citrus latifolia), cereals and cereal products, japanese pumpkins (Cucurbita maxima), and climbing beans (Vigna umbellata). This could make psoralen a potential biomarker for the consumption of these foods. Based on a literature review a significant number of articles have been published on Psoralen. |
|---|
| CAS Number | 66-97-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 3-(6-Hydroxy-5-benzofuranyl)-2-propenoic acid delta-lactone | ChEBI | | 6,7-Furanocoumarin | ChEBI | | 6-Hydroxy-5-benzofuranacrylic acid delta-lactone | ChEBI | | 7H-Furo[3,2-g][1]benzopyran-7-one | ChEBI | | Ficusin | ChEBI | | Furo[2',3':7,6]coumarin | ChEBI | | Furo[4',5':6,7]coumarin | ChEBI | | Furocoumarin | ChEBI | | Manaderm | ChEBI | | Psoralene | ChEBI | | 7H-Furo[3,2-g]chromen-7-one | Kegg | | 3-(6-Hydroxy-5-benzofuranyl)-2-propenoate delta-lactone | Generator | | 3-(6-Hydroxy-5-benzofuranyl)-2-propenoate δ-lactone | Generator | | 3-(6-Hydroxy-5-benzofuranyl)-2-propenoic acid δ-lactone | Generator | | 6-Hydroxy-5-benzofuranacrylate delta-lactone | Generator | | 6-Hydroxy-5-benzofuranacrylate δ-lactone | Generator | | 6-Hydroxy-5-benzofuranacrylic acid δ-lactone | Generator | | 2H-furo[3,2-g]Chromen-2-one | HMDB | | 5-Benzofuranacrylic acid, 6-hydroxy-, delta-lactone | HMDB | | 6-Hydroxy-5-benzofuranacrylic acid beta-lactone | HMDB | | 6-Hydroxy-5-benzofuranacrylic acid gamma-lactone | HMDB | | 7H-furo(3,2-g)(1)Benzopyran-7-one | HMDB | | 7H-furo[3,2-g]Benzopyran-7-one | HMDB | | 7H-furo[3,2-g][1]Benzopyran-7-one, 9ci | HMDB | | furo(2',3',7,6)Coumarin | HMDB | | furo(3,2-g)-Coumarin | HMDB | | furo(4',5',6,7)Coumarin | HMDB | | furo[2'.3':7.6]Coumarin | HMDB | | furo[3,2-g]Coumarin | HMDB | | Phytoalexin | HMDB | | Phytoalexin-CMPD | HMDB | | Psorline-P | HMDB | | 2H-Furo[3,2-g]chromen-2-one | db_source | | 3-(6-hydroxy-5-benzofuranyl)-2-propenoic acid delta-lactone | biospider | | 6-hydroxy-5-benzofuranacrylic acid delta-lactone | biospider | | 6-hydroxy-5-benzofuranacrylic acid gamma-lactone | biospider | | 7H-Furo(3,2-g)(1)benzopyran-7-one | biospider | | 7H-Furo[3,2-g][1]benzopyran-7-one, 9CI | db_source | | 7H-Furo[3,2-g]benzopyran-7-one | biospider | | Furo(2',3',7,6)coumarin | biospider | | Furo(3,2-g)-coumarin | biospider | | Furo(4',5',6,7)coumarin | biospider | | Furo[2'.3':7.6]coumarin | biospider | | Furo[3,2-g]coumarin | biospider | | Psorline-p | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C11H6O3 |
|---|
| IUPAC name | 7H-furo[3,2-g]chromen-7-one |
|---|
| InChI Identifier | InChI=1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H |
|---|
| InChI Key | ZCCUUQDIBDJBTK-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | O=C1OC2=CC3=C(C=CO3)C=C2C=C1 |
|---|
| Average Molecular Weight | 186.166 |
|---|
| Monoisotopic Molecular Weight | 186.031694053 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Coumarins and derivatives |
|---|
| Sub Class | Furanocoumarins |
|---|
| Direct Parent | Psoralens |
|---|
| Alternative Parents | |
|---|
| Substituents | - Psoralen
- Benzopyran
- 1-benzopyran
- Benzofuran
- Pyranone
- Benzenoid
- Pyran
- Furan
- Heteroaromatic compound
- Lactone
- Oxacycle
- Organoheterocyclic compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 70.97%; H 3.25%; O 25.78% | DFC |
|---|
| Melting Point | Mp 171° (161-162°, 165°) | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | 1.67 | (IN PRESS) |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | 310 (e 8000) (EtOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-052r-3900000000-eff7b2146482de5c7740 | 2014-09-20 | View Spectrum | | GC-MS | Psoralen, non-derivatized, GC-MS Spectrum | splash10-0pbi-0900000000-f4158c6b7c0ecf20d9fe | Spectrum | | GC-MS | Psoralen, non-derivatized, GC-MS Spectrum | splash10-0r2i-6900000000-276c6db470fc13777449 | Spectrum | | GC-MS | Psoralen, non-derivatized, GC-MS Spectrum | splash10-0pbi-0900000000-f4158c6b7c0ecf20d9fe | Spectrum | | GC-MS | Psoralen, non-derivatized, GC-MS Spectrum | splash10-0r2i-6900000000-276c6db470fc13777449 | Spectrum | | Predicted GC-MS | Psoralen, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-052u-1900000000-900e13490ddfba7e89ef | Spectrum | | Predicted GC-MS | Psoralen, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Psoralen, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - LC-ESI-qTof , Positive | splash10-00lr-1900000000-ac91ad62c36a29665a71 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-000i-0900000000-75211365e04f08273288 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-00lr-0900000000-fa9d08e8d5421ebeaa77 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF , positive | splash10-0f89-0900000000-bacd49139ec536fb55e7 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-00lr-1900000000-ac91ad62c36a29665a71 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-001r-0900000000-195d9e7e3b29cf95c327 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0900000000-75211365e04f08273288 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-00lr-0900000000-fa9d08e8d5421ebeaa77 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-0f89-0900000000-bacd49139ec536fb55e7 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0900000000-287480067e742345fcb9 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0900000000-2bf4a5ffe9d6883b015e | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-1900000000-519db61c8cb6a8a31549 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0900000000-559cba64d14574cb0041 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0900000000-503a6a3d5ba551e5c0f5 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-0900000000-857f114f045cf9aa2b39 | 2015-05-27 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0900000000-f3f07adc83a68e9e76ff | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-0900000000-f3f07adc83a68e9e76ff | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4i-0900000000-a2c2c14d0cf6b23ada92 | 2021-09-23 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0900000000-89e4df10d3690e5a6d15 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-0900000000-89e4df10d3690e5a6d15 | 2021-09-24 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-000i-0900000000-89e4df10d3690e5a6d15 | 2021-09-24 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CDCl3, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 5964 |
|---|
| ChEMBL ID | CHEMBL164660 |
|---|
| KEGG Compound ID | C09305 |
|---|
| Pubchem Compound ID | 6199 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 27616 |
|---|
| Phenol-Explorer ID | 718 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB34272 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HJG27-Y:HJG27-Y |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | FICUSIN|PSORALEN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00000297 |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Psoralen |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti depressant | 52217 | An agent that regulates mood, reducing symptoms of depression and anxiety by altering neurotransmitter levels in the brain, commonly used in managing depression, anxiety disorders, and other mood disorders. | DUKE | | Anti leukodermic | | An agent that treats leucoderma (vitiligo), characterized by white skin patches or total loss of pigmentation, promoting skin repigmentation and reducing disease progression, commonly used in dermatology to manage vitiligo and other skin pigmentation disorders. | DUKE | | Anti mitotic | | An agent that inhibits mitosis, or cell division, playing a crucial role in regulating cell growth. Therapeutically, it is used to treat cancer by blocking tumor cell proliferation. Key medical uses include chemotherapy for various cancers, such as breast, lung, and colon cancer, to prevent cancer cell division and growth. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-psoriac | 52217 | An agent that reduces psoriasis symptoms, commonly used in managing plaque psoriasis, scalp psoriasis, and other inflammatory skin conditions, by inhibiting cell growth, reducing inflammation, and modulating the immune system. | DUKE | | Anti-spasmodic | 52217 | An agent that relaxes smooth muscle, reducing muscle spasms and cramps. It plays a biological role in regulating muscle tone and is therapeutically applied to treat conditions such as irritable bowel syndrome, menstrual cramps, and muscle spasms, providing relief from abdominal pain and discomfort. | DUKE | | Anti-tubercular | 33282 | An agent that combats tuberculosis, playing a biological role in inhibiting the growth of Mycobacterium tuberculosis. Therapeutically, it is used to treat and prevent tuberculosis, with key medical applications including the treatment of active TB, latent TB, and TB meningitis, as well as preventing the spread of TB in high-risk populations. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Antitumor promoter | 35610 | An agent that inhibits tumor growth and progression, reducing cancer cell proliferation. Therapeutically, it prevents tumor development and spread, with key medical uses in cancer prevention and treatment, particularly in combating carcinogenesis and metastasis. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Artemicide | | An herbicidal agent that targets and eliminates weeds of the Artemisia genus, with potential therapeutic applications in allergy management and anti-inflammatory uses, particularly for conditions exacerbated by Artemisia allergens. | DUKE | | Bacteriophagicide | 33282 | An agent that kills bacteriophages, reducing their ability to infect bacteria. Its biological role is to regulate phage populations, and it has therapeutic applications in phage therapy, where it can be used to prevent phage-mediated bacterial lysis, and key medical uses include treating phage-borne bacterial infections. | DUKE | | Calcium antagonist | 48706 | A medication that blocks calcium ion entry into cells, reducing muscle contraction and vascular resistance. It treats hypertension, angina, and arrhythmias by dilating blood vessels and decreasing cardiac workload, commonly used in managing cardiovascular diseases. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Contraceptive | 52217 | An agent that prevents pregnancy by inhibiting ovulation, fertilization, or implantation, used to control birth rates, manage menstrual disorders, and reduce the risk of sexually transmitted infections, commonly applied in various forms such as pills, injections, and barrier methods. | DUKE | | Cytotoxic | 52209 | An agent that kills or damages cells, playing a biological role in immune responses and therapeutic applications in cancer treatment. Key medical uses include chemotherapy, targeting and destroying cancer cells, and treating certain autoimmune diseases by eliminating harmful cells. | DUKE | | Fungicide | 24127 | An agent that kills or inhibits the growth of fungi, playing a biological role in preventing fungal infections. Therapeutically, it is used to treat fungal diseases, with key medical applications including athlete's foot, ringworm, and candidiasis, as well as agricultural uses to protect crops from fungal damage. | DUKE | | Genotoxic | 50902 | An agent that damages genetic material, disrupting DNA structure and function. It has a biological role in inducing mutations and cancer. Therapeutically, genotoxic agents are used in chemotherapy to target rapidly dividing cancer cells. Key medical uses include cancer treatment, with applications in oncology for killing malignant cells and inhibiting tumor growth. | DUKE | | Hypotensive | | An agent that lowers blood pressure, playing a biological role in regulating cardiovascular function. Therapeutically, it's used to manage hypertension, heart failure, and angina, with key medical applications in preventing stroke, kidney disease, and cardiac complications. | DUKE | | Insecticide | 24852 | An agent that kills or repels insects, used to control pests and prevent disease transmission. Therapeutically, insecticides have applications in public health and veterinary medicine, key medical uses include controlling insect-borne diseases such as malaria, typhus, and Lyme disease. | DUKE | | Monoamine-oxidase-A inhibitor | 23924 | An agent that blocks monoamine oxidase A, an enzyme breaking down neurotransmitters like serotonin and norepinephrine. Therapeutically, it increases their levels, commonly used in managing depression, anxiety disorders, and certain neurodegenerative diseases. | DUKE | | Monoamine-oxidase-B inhibitor | 23924 | An agent that blocks monoamine oxidase B enzyme, reducing dopamine breakdown. Therapeutically, it increases dopamine levels, used to manage Parkinson's disease symptoms, and has neuroprotective effects, potentially slowing disease progression. | DUKE | | Mutagenic | | An agent that induces genetic mutations, altering DNA sequences. It plays a biological role in evolution and adaptation. Therapeutically, mutagenic agents are used in cancer treatment, such as chemotherapy, and in gene therapy to introduce beneficial traits. Key medical uses include oncology and genetic research. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Photocarcinogenic | 50903 | An agent that increases the risk of skin cancer upon exposure to light, particularly UV radiation. It plays a biological role in damaging skin cells' DNA, leading to tumor formation. Therapeutically, understanding photocarcinogenic effects is crucial in developing sunscreens and protective measures. Key medical uses include warning labels on photosensitizing medications and educating patients on sun protection to prevent skin cancer. | DUKE | | Phototoxic | | An agent that causes skin damage, such as sunburn or blisters, upon exposure to light, especially ultraviolet light, with no therapeutic applications but key medical uses in diagnosing photosensitivity disorders. | DUKE | | Phytoalexin | 26115 | A plant-derived compound that plays a biological role in defense against pathogens. It has therapeutic applications as an antimicrobial, antioxidant, and anti-inflammatory agent, with key medical uses in managing infections, cancer, and neurodegenerative diseases. | DUKE | | Topoisomerase-II inhibitor | 50750 | An agent that blocks the activity of topoisomerase-II, an enzyme involved in DNA replication. It prevents cancer cell growth by disrupting DNA structure, commonly used in chemotherapy to treat various types of cancer, including leukemia and lymphoma. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181. — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070.
|
|---|